PubRank

Yingbo Na

Author PubWeight™ 27.66‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Angiographic surrogate end points in drug-eluting stent trials: a systematic evaluation based on individual patient data from 11 randomized, controlled trials. J Am Coll Cardiol 2008 2.54
2 Hemodialysis vascular access modifies the association between dialysis modality and survival. J Am Soc Nephrol 2011 2.13
3 Increased hemodialysis catheter use in Canada and associated mortality risk: data from the Canadian Organ Replacement Registry 2001-2004. Clin J Am Soc Nephrol 2008 1.61
4 Impact of dialysis modality on survival after kidney transplant failure. Clin J Am Soc Nephrol 2011 1.61
5 Low hematocrit predicts contrast-induced nephropathy after percutaneous coronary interventions. Kidney Int 2005 1.57
6 Association between estimated glomerular filtration rate at initiation of dialysis and mortality. CMAJ 2010 1.50
7 Impact of platelet glycoprotein IIb/IIIa receptor inhibitors on outcomes of diabetic patients undergoing percutaneous coronary interventions using sirolimus-eluting stents. Catheter Cardiovasc Interv 2008 1.39
8 Development and validation of a prognostic risk score for major bleeding in patients undergoing percutaneous coronary intervention via the femoral approach. Eur Heart J 2007 1.37
9 Impact of baseline platelet count in patients undergoing primary percutaneous coronary intervention in acute myocardial infarction (from the CADILLAC trial). Am J Cardiol 2007 1.35
10 Drug-eluting stents in the treatment of intermediate lesions: pooled analysis from four randomized trials. J Am Coll Cardiol 2006 1.17
11 Impact of routine angiographic follow-up on the clinical benefits of paclitaxel-eluting stents: results from the TAXUS-IV trial. J Am Coll Cardiol 2006 1.14
12 Changes in patient and technique survival over time among incident peritoneal dialysis patients in Canada. Clin J Am Soc Nephrol 2012 1.14
13 Impact of time to treatment on myocardial reperfusion and infarct size with primary percutaneous coronary intervention for acute myocardial infarction (from the EMERALD Trial). Am J Cardiol 2007 1.04
14 Impact of anemia on outcomes of patients undergoing percutaneous coronary interventions. Am J Cardiol 2004 0.95
15 Association between vascular access type and patient mortality among elderly patients on hemodialysis in Canada. Hemodial Int 2014 0.94
16 Intravascular ultrasound assessment of drug-eluting stent expansion. Am Heart J 2007 0.92
17 Nonrandomized comparison of coronary stenting under intravascular ultrasound guidance of direct stenting without predilation versus conventional predilation with a semi-compliant balloon versus predilation with a new scoring balloon. Am J Cardiol 2007 0.87
18 Overview of the Canadian pediatric end-stage renal disease database. BMC Nephrol 2010 0.87
19 Impact of in-hospital acquired thrombocytopenia in patients undergoing primary angioplasty for acute myocardial infarction. Am J Cardiol 2005 0.85
20 Prognostic significance of cerebrovascular and peripheral arterial disease in patients having percutaneous coronary interventions. Am J Cardiol 2004 0.83
21 Usefulness of routine unfractionated heparin infusion following primary percutaneous coronary intervention for acute myocardial infarction in patients not receiving glycoprotein IIb/IIIa inhibitors. Am J Cardiol 2006 0.79
22 DOPPS estimate of patient life years attributable to modifiable hemodialysis practices in Canada. Nephrol News Issues 2007 0.78
23 Outcomes of patients consented but not randomized in a trial of primary percutaneous coronary intervention in acute myocardial infarction (the CADILLAC registry). Am J Cardiol 2005 0.76
24 Continuous mortality risk among peritoneal dialysis patients. Arch Intern Med 2012 0.75